Biocentis Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
24
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$5.91M
- Investors
-
8
Biocentis General Information
Description
Operator of a genetic control technology designed to target harmful insect species that transmit diseases, destroy crops, and threaten biodiversity. The company offers innovative, precision-driven genetic techniques, enabling agriculture, public health, and environmental sectors to reduce the impact of insect-borne threats, fostering healthier ecosystems and improved crop yields.
Contact Information
Website
www.biocentis.comCorporate Office
- 22 Glassworks Studios
- Basing Place
- London E2 8AB
- England, United Kingdom
Corporate Office
- 22 Glassworks Studios
- Basing Place
- London E2 8AB
- England, United Kingdom
Biocentis Timeline
Biocentis Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Grant | 18-Nov-2025 | $5.91M | Completed | Startup | ||
| 6. Seed Round | 18-Nov-2025 | Completed | Startup | |||
| 5. Seed Round | 01-Jan-2024 | Completed | Startup | |||
| 4. Grant | 14-Oct-2023 | Completed | Startup | |||
| 3. Accelerator/Incubator | 10-Jul-2023 | Completed | Startup | |||
| 2. Seed Round | 27-Jan-2022 | $1.13M | $1.13M | Completed | Startup | |
| 1. University Spin-Out | 13-Jan-2022 | Completed | Startup |
Biocentis Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed Preferred | ||||||||
| Seed Preferred | ||||||||
| Ordinary | 119,199 | $0.000116 | $8.1 | $8.1 | 1x | $8.1 | 12.49% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Biocentis Signals
Biocentis Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Algebris | Asset Manager | Minority | ||
| The Grantham Foundation | Limited Partner | Minority | ||
| Wellcome Trust | Limited Partner | |||
| Corbites | Venture Capital | Minority | ||
| Novaterra Holding | Venture Capital | Minority |
Biocentis FAQs
-
When was Biocentis founded?
Biocentis was founded in 2022.
-
Where is Biocentis headquartered?
Biocentis is headquartered in London, United Kingdom.
-
What is the size of Biocentis?
Biocentis has 24 total employees.
-
What industry is Biocentis in?
Biocentis’s primary industry is Biotechnology.
-
Is Biocentis a private or public company?
Biocentis is a Private company.
-
What is Biocentis’s current revenue?
The current revenue for Biocentis is .
-
How much funding has Biocentis raised over time?
Biocentis has raised $13.9M.
-
Who are Biocentis’s investors?
Algebris, The Grantham Foundation, Wellcome Trust, Corbites, and Novaterra Holding are 5 of 8 investors who have invested in Biocentis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process